Diabetic nephropathy. Type 2 diabetes mellitus with diabetic nephropathy
Conditions
Interventions
Intervention 1: Intervention group: Includes 20 patients aged between 30 and 70 years who have developed diabetic nephropathy within the past 1 to 10 years. After reviewing the study's inclusion and e
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age 30 to 70 years Patients with diabetic nephropathy in stages 1 to 4 of renal failure classification according to guidelines Duration of diabetic nephropathy between 1 and 10 years
Exclusion criteria
Exclusion criteria: Taking any vitamin or mineral supplements containing coenzyme Q10 Pregnancy or breastfeeding for women of childbearing age Liver dysfunction (AST or ALT More than 3 times the normal limit) Having any type of cancer in the past or now Patients with ESRD
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glomerular Filtration Rate Biomarker. Timepoint: Blood tests were taken at the beginning of the study (before the intervention) and 8 weeks after starting CoQ10 supplementation. Method of measurement: Blood tests for patients.;Blood Urea Nitrogen Biomarker. Timepoint: Blood tests were taken at the beginning of the study (before the intervention) and 8 weeks after starting CoQ10 supplementation. Method of measurement: Blood tests for patients.;Creatinine biomarker. Timepoint: Blood tests were taken at the beginning of the study (before the intervention) and 8 weeks after starting CoQ10 supplementation. Method of measurement: Blood tests for patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Maryam shiehmorteza
Islamic Azad University
Outcome results
None listed